SOMERSET, N.J. – December 11, 2023 – Terumo Medical Corporation, a subsidiary of Terumo Corporation, today announced the launch of the AZUR™ HydroPack™ Peripheral Coil System, a new embolization coil solution designed to provide a soft-packing, long-lasting solution for embolotherapy procedures.
The AZUR HydroPack System combines Terumo's proprietary hydrogel-coated coil technology with a soft primary coil, designed to conform to complex vascular anatomy and provide durable vessel occlusion for a range of peripheral embolization procedures.
"The AZUR HydroPack System reflects our continued investment in embolization technologies that help physicians achieve reliable, long-lasting occlusion outcomes for their patients," said a Terumo Medical Corporation representative. "This launch builds on our long history of innovation in the embolotherapy space."
The system is now available to interventional physicians across the United States for use in peripheral vascular embolization procedures.
About Terumo Medical Corporation
Terumo Medical Corporation, a subsidiary of Terumo Corporation, develops, manufactures and markets a broad range of medical devices used in interventional and surgical procedures worldwide.
About Terumo
Terumo (TSE: 4543) is a leading global provider of medical products and solutions with net sales of 4 billion USD. Founded in 1921, Terumo employs over 30,000 associates worldwide, and its products and services are available in more than 160 countries and regions. Terumo's stated mission is "Contributing to Society through Healthcare."
